Our technologies have wide applications in improving the efficacy and safety of cell and gene therapies.
A unique partnering opportunity
Locate has a unique opportunity of bringing these powerful technologies together, to realise the promise of cell and gene therapies as a potentially curative approaches, both for our partners and our in-house programmes, to improve the lives of patients worldwide.
In addition to medical applications, both technologies also have tremendous opportunities in improving the cost-efficiency of manufacture of cell and gene therapy products. Locate provides non-exclusive licenses to third parties for such applications.
Locate follows a hybrid business model; having in-house product development initiatives (e.g. combination products for orthopedic repair) running in tandem with a platform approach (i.e. partnered programmes for a wide array of regenerative medicine applications).
Our delivery systems are available for partnering or out-licensing across a wide array of cell therapy, drug delivery and gene therapy applications, as follows:
A unique injectable, yet highly porous, delivery scaffold for precision delivery of cells and drugs to the regenerative site.
Cellular uptake peptide with low toxicity and superior efficiency.
Porous 3D matrix for trypsin-free culture.